Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM–PLGA microspheres for bone cancer treatment
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
To develop adriamycin (ADM)-encapsulated poly(lactic-co-glycolic acid) (PLGA) nanoparticles in a porous nano-hydroxyapatite/collagen scaffold (ADM-PLGA-NHAC). To provide novel strategies for future treatment of osteosarcoma, the properties of the scaffold, including its in vitro extended-release properties, the inhibition effects of ADM-PLGA-NHAC on the osteosarcoma MG63 cells, and its bone repair capacity, were investigated in vivo and in vitro. The PLGA copolymer was utilized as a drug carrier to deliver ADM-PLGA nanoparticles (ADM-PLGA-NP). Porous nano-hydroxyapatite and collagen were used to materials to produce the porous nano-hydroxyapatite/collagen scaffold (NHAC), into which the ADM-PLGA-NP was loaded. The performance of the drug-carrying scaffold was assessed using multiple techniques, including scanning electron microscopy and in vitro extended release. The antineoplastic activities of scaffold extracts on the human osteosarcoma MG63 cell line were evaluated in vitro using the cell counting kit-8 (CCK8) method and live-dead cell staining. The bone repair ability of the scaffold was assessed based on the establishment of a femoral condyle defect model in rabbits. ADM-PLGA-NHAC and NHAC were implanted into the rat muscle bag for immune response experiments. A tumor-bearing nude mice model was created, and the TUNEL and HE staining results were observed under optical microscopy to evaluate the antineoplastic activity and toxic side effects of the scaffold. The composit…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The scaffold possessed an extended drug release pattern for 28 d where 65% of the drug was released from the scaffold over the stipulated period.”
From Nano-hydroxyapatite/collagen composite as scaffold material for bone regeneration. (2023) · cites this paper as [70]
In the citing paper
“The results proved that the nano-HA/collagen scaffold not only improves the bone regeneration process but also can be loaded with drugs for disease conditions like osteosarcoma.”
From Nano-hydroxyapatite/collagen composite as scaffold material for bone regeneration. (2023) · cites this paper as [70]
In the citing paper
“The tumor weights in groups A, B, C, and D were 3.36 ± 0.29 g, 1.54 ± 0.17 g, 1.82 ± 0.14 g, and 1.11 ± 0.09 g respectively (figure 4(a3)).”
From Nano-hydroxyapatite/collagen composite as scaffold material for bone regeneration. (2023) · cites this paper as [70]
In the citing paper
“From the study, group D was found to possess a significantly lower value than the other three groups with respect to tumor volume and tumor weight (figures 4(a1)-(d1) and (a2)-(d2)).”
From Nano-hydroxyapatite/collagen composite as scaffold material for bone regeneration. (2023) · cites this paper as [70]
In the citing paper
“The tumor volume of groups A, B, C, and D were 9.72 ± 0.72 cm 3 , 4.24 ± 0.31 cm 3 , 5.57 ± 0.37 cm 3 , and 2.68 ± 0.22 cm 3 respectively (figure 4(b3)).”
From Nano-hydroxyapatite/collagen composite as scaffold material for bone regeneration. (2023) · cites this paper as [70]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Link, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142502 · Cited by 1,204
Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery
Rosen, G., Marcove, R. C., Caparros, B., Nirenberg, A., Kosloff, C., & Huvos, A. G. (1979) · Cancer · doi:10.1002/1097-0142(197906)43:6<2306::aid-cncr2820430621>3.0.co;2-k · Cited by 585
Uskoković, V., & Uskoković, D. P. (2011) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.31746 · Cited by 538
Nanocrystalline calcium phosphate ceramics in biomedical engineering
Kalita, S. J., Bhardwaj, A., & Bhatt, H. A. (2007) · Materials Science and Engineering: C · doi:10.1016/j.msec.2006.05.018 · Cited by 522
Bacci, G., Ferrari, S., Bertoni, F., Ruggieri, P., Picci, P., Longhi, A., Casadei, R., Fabbri, N., Forni, C., Versari, M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.24.4016 · Cited by 438
Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegard, T. A., Picci, P., Capanna, R., Bernini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5785 · Cited by 435
Role of hydroxyapatite nanoparticle size in bone cell proliferation
Cai, Y., Liu, Y., Yan, W., Hu, Q., Tao, J., Zhang, M., Shi, Z., & Tang, R. (2007) · Journal of Materials Chemistry · doi:10.1039/b705129h · Cited by 407
Moore, D. D., & Luu, H. H. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-319-07323-1_4 · Cited by 349
Cited by
Synthesis of hydroxyapatite for biomedical applications
Szcześ, A., Hołysz, L., & Chibowski, E. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.04.007 · Cited by 719
Hydroxyapatite–polymer biocomposites for bone regeneration: A review of current trends
Ramesh, N., Moratti, S. C., & Dias, G. J. (2018) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.33950 · Cited by 358
Mo, X., Zhang, D., Liu, K., Zhao, X., Li, X., & Wang, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021291 · Cited by 188
Panda, S., Biswas, C. K., & Paul, S. (2021) · Ceramics International · doi:10.1016/j.ceramint.2021.07.100 · Cited by 167
N-acetyl cysteine-loaded graphene oxide-collagen hybrid membrane for scarless wound healing
Li, J., Zhou, C., Luo, C., Qian, B., Liu, S., Zeng, Y., Hou, J., Deng, B., Sun, Y., Yang, J., et al. (2019) · Theranostics · doi:10.7150/thno.34480 · Cited by 117
“Besides, collagen lacks antioxidant properties resulting in poor performance in regulating the wound environment [23].”
Background
Metadata
- Authors
- Rong, Z.-J., Yang, L.-J., Cai, B.-T., Zhu, L.-X., Cao, Y.-L., Wu, G.-F., & Zhang, Z.-J.
- Affiliations
- Zhujiang Hospital (CN)
- Venue
- Journal of Materials Science: Materials in Medicine
- Published
- 2016-03-14
- Volume
- 27
- Issue
- 5
- Pages
- 89-89
- ISSN
- 0957-4530 (ISSN-L)
- 1573-4838
- OpenAlex
- W2299522681
- Cited by
- 65
- References
- 25
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 9 · 2023: 11 · 2022: 6 · 2021: 7 · 2020: 9 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 2
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Materials Science Materials in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science and Technology Program of Guangzhou, China (2011Y2-00023-2)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- doxorubicin, PLGA nanoparticles, drug delivery, osteosarcoma, bone cancer, sustained drug release, bone regeneration, biocompatibility, anticancer activity, femoral condyle defect, tumor-bearing nude mice, osteoconductive scaffolds
- MeSH terms
- Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Antibiotics, Antineoplastic, Bone Neoplasms, Collagen, Doxorubicin, Female, Humans, Male, Mice, Nude, Polyglycolic Acid, Rabbits, Osteosarcoma, Rats, Sprague-Dawley, Durapatite, Lactic Acid, Cell Line, Tumor, Nanostructures, Mice, Rats, Tissue Scaffolds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM–PLGA microspheres for bone cancer treatment. https://app.cochat.ai/papers/10.1007/s10856-016-5699-0
- The paper
- Rong, Z.-J., Yang, L.-J., Cai, B.-T., Zhu, L.-X., Cao, Y.-L., Wu, G.-F., & Zhang, Z.-J. (2016). Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM–PLGA microspheres for bone cancer treatment. Journal of Materials Science: Materials in Medicine. https://doi.org/10.1007/s10856-016-5699-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.